$21.40
1.20% yesterday
NYSE, Oct 15, 10:00 pm CET
ISIN
IE00BGH1M568
Symbol
PRGO

Perrigo Company Stock price

$21.38
-0.37 1.70% 1M
-3.68 14.68% 6M
-4.33 16.84% YTD
-2.92 12.02% 1Y
-17.89 45.56% 3Y
-25.32 54.22% 5Y
-141.24 86.85% 10Y
+8.25 62.83% 20Y
NYSE, Closing price Wed, Oct 15 2025
-0.28 1.29%

Key metrics

Basic
Market capitalization
$3.0b
Enterprise Value
$6.2b
Net debt
$3.2b
Cash
$454.2m
Shares outstanding
137.6m
Valuation (TTM | estimate)
P/E
negative | 7.1
P/S
0.7 | 0.7
EV/Sales
1.4 | 1.4
EV/FCF
24.1
P/B
0.7
Dividends
DPS
$1.10
Yield 1Y | 5Y
5.1% | 2.6%
Growth 1Y | 5Y
1.1% | 6.1%
Payout 1Y | 3Y
-88.3% | -136.0%
Increased
22 Years
Financials (TTM | estimate)
Revenue
$4.3b | $4.5b
EBITDA
$742.0m | $788.8m
EBIT
$413.2m | $681.3m
Net Income
$-80.3m | $419.7m
Free Cash Flow
$256.7m
Growth (TTM | estimate)
Revenue
-2.3% | 2.3%
EBITDA
36.8% | 23.7%
EBIT
104.5% | 118.4%
Net Income
35.5% | 344.3%
Free Cash Flow
12.0%
Margin (TTM | estimate)
Gross
35.7%
EBITDA
17.2% | 17.6%
EBIT
9.6%
Net
-1.9% | 9.4%
Free Cash Flow
5.9%
Financial Health
Equity Ratio
44.8%
Return on Equity
-4.0%
ROCE
4.6%
ROIC
-2.6%
Debt/Equity
0.8
More
EPS
$-0.6
FCF per Share
$1.9
Short interest
7.1%
Employees
8k
Rev per Employee
$520.0k
Show more

Is Perrigo Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Perrigo Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Perrigo Company forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a Perrigo Company forecast:

Buy
70%
Hold
30%

Financial data from Perrigo Company

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
4,326 4,326
2% 2%
100%
- Direct Costs 2,781 2,781
2% 2%
64%
1,546 1,546
3% 3%
36%
- Selling and Administrative Expenses 1,061 1,061
13% 13%
25%
- Research and Development Expense 103 103
13% 13%
2%
742 742
37% 37%
17%
- Depreciation and Amortization 329 329
3% 3%
8%
EBIT (Operating Income) EBIT 413 413
104% 104%
10%
Net Profit -80 -80
36% 36%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about Perrigo Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Perrigo Company Stock News

Neutral
PRNewsWire
6 days ago
Brands Will Donate One Pack of Opill® to NY Birth Control Access Project for Each Opill®-Themed Chill Tips Set Sold GRAND RAPIDS, Mich. , Oct. 9, 2025 /PRNewswire/ -- Today, Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced that Opill® — the first and only daily birth control pill available without a prescription in the U.S. —is partnering with self-...
Positive
Seeking Alpha
20 days ago
The article highlights the top ten S&P Hi-Yield Aristocrats for September, with nine stocks offering attractive yields and fair pricing for dividend investors. Analyst forecasts project potential net gains of 21.59% to 66.98% by September 2026 for these high-yield 'dog' stocks, with average risk 31% below the market. Five lowest-priced Hi-Yield Aristocrats—AMCR, FLO, PRGO, BEN, RHI—are expected...
Neutral
PRNewsWire
about 2 months ago
DUBLIN , Aug. 20, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to participate in one-on-one investor meetings at the Barclays Global Consumer Staples Conference on Wednesday, September 3 rd, 2025. About Perrigo    Perrigo Company plc i...
More Perrigo Company News

Company Profile

Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the U.S., Mexico and Canada consumer healthcare business. The Consumer Self-Care International segment includes branded consumer healthcare business primarily in Europe and consumer focused businesses in the U.K., Australia, and Israel. The Prescription Pharmaceuticals refers to the U.S. prescription pharmaceuticals business. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

Head office United States
CEO Patrick Lockwood-Taylor
Employees 8,379
Founded 1887
Website www.perrigo.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today